Xing Ling International Pte Ltd

Xing Ling distributes a range of

- Western (generic) drugs

- Supplements

- Traditional and Scientific Chinese Medicine

- Treated Herbs

We are actively looking for strategic partners to bring extend the distribution of our products.

Activity:

- Contract Manufacturing
- Licensing & Business Development
- Market Research & Marketing
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Generics
- FP (finished products)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins

Therapeutic targets:

- Aging
- Allergy
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Men's Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Orthopedics
- Pain
- Reproductive Health
- Respiratory Medicine
- Stroke
- Tonics
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Asia , Near/Middle East , Europe , North America

c. Countries active: Singapore, Malaysia, Indonesia, Cambodia, Japan, Korea, Oman, Italy, U.S

Corporate data:

Number of Employees: 10

Turnover:

Amount:	Year:	Currency:
250000	2006	US Dollar

Year founded: 2005

Partners / Alliances: Parent Company: Orchid Capital, listed on Germany and Australia stock exchange (www.orchidcapital.com)

Global Representative: Topsun Group (www.topsun.com), Kinna Group